FDA has issued warning letters to two companies for illegally selling unapproved products containing cannabidiol (CBD) in ways that violate the FD&C Act, including claims that they can treat medical conditions, including opioid addiction.
from FDA Press Releases RSS Feed https://ift.tt/2S2ikKD
via IFTTT
No comments:
Post a Comment